DNV has been selected to certify Class D diagnostic devices for a prominent U.S. manufacturer, marking a significant development under the European Union’s In Vitro Diagnostic Regulation (IVDR). This partnership reflects the growing need for manufacturers to transition legacy devices to comply with new regulatory standards while maintaining access to the European market.
Understanding IVDR
The IVDR, which came into effect in 2017, replaces the previous In Vitro Diagnostic Directive 98/79/EC. This regulation introduces heightened scrutiny for diagnostic devices, mandating stricter clinical evidence requirements and increasing the role of notified bodies in the certification process. As a designated Notified Body, DNV plays a crucial role in enabling manufacturers to navigate these complexities.
DNV’s Credentials
Since its designation as a Notified Body under the IVDR in May 2025, DNV has leveraged its extensive experience in medical device certification. DNV’s expertise not only aids manufacturers in understanding the intricacies of regulatory compliance but also ensures their continued access to international markets.
Building on Established Relationships
The U.S. manufacturer selecting DNV already has a history of collaboration, having previously certified various devices under different regulatory frameworks, including the Medical Device Single Audit Program (MDSAP). This existing relationship underscores the trust and confidence that the manufacturer places in DNV’s capabilities.
Streamlining the Certification Process
The certification activities for the IVDR will be conducted through DNV’s innovative digital certification platform. This advanced platform enables manufacturers to upload and manage their technical and performance documentation in a secure environment. By facilitating efficient collaboration during the review process, DNV enhances transparency, streamlining workflows and expediting the certification timeline.
Collaborative Project Management
A representative from the U.S. manufacturer expressed their appreciation for DNV’s tailored approach to certification. They emphasized DNV’s flexibility in project management and the importance of customized timelines in meeting regulatory demands. The support DNV provides in post-certification processes is also crucial for easing the transition to IVDR compliance.
Commitment to Efficiency and Transparency
Cecilie Gudesen Torp, VP and Managing Director of Medical Technologies at DNV, highlighted the organization’s dedication to supporting manufacturers in achieving IVDR certification. DNV aims to make the certification process as efficient and transparent as possible, combining collaborative project management with digital tools to simplify documentation and communication.
In conclusion, DNV’s selection by a leading U.S. diagnostics manufacturer marks a pivotal moment in the adherence to EU IVDR standards. This collaboration not only reinforces the manufacturer’s market presence but also demonstrates DNV’s commitment to facilitating smooth transitions in the ever-evolving regulatory landscape.
- Key Takeaways:
- DNV has been designated as a Notified Body under the IVDR, enhancing its role in medical device certification.
- The IVDR introduces stricter requirements for diagnostic devices, necessitating robust compliance strategies.
- DNV’s digital certification platform streamlines the certification process, improving efficiency and transparency.
- Established relationships between manufacturers and DNV foster confidence in navigating regulatory changes.
- DNV’s flexible project management approach is crucial for manufacturers adapting to new regulations.
Read more → www.manilatimes.net